Form 4 for GILD Gilead Sciences
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-10 · accession 0001127602-22-025411 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-14 | 2022-11-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | +5,099 | 47.8K | +12% | — |
| D | 2022-11-14 | 2022-11-10 | GILD | Parsey Merdad | Chief Medical Off | F - Tax | $82.60 | -2,268 | 45.6K | -5% | -$187.3K |
| D | 2022-11-14 | 2022-11-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | -5,099 | 45.1K | -10% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-10 | M | A | 5,099 | — | 47,824 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2022-11-10 | F | D | 2,268 | $82.60 | 45,556 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-11-10 | M | D | 5,099 | — | 45,140 | D | — · — to — | 5,099 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. |